A citation-based method for searching scientific literature

F Le Deist, J F Emile, F Rieux-Laucat, M Benkerrou, I Roberts, N Brousse, A Fischer. Lancet 1996
Times Cited: 152







List of co-cited articles
488 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
68

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
66

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
44

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
465
43

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
347
36

Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.
A Bettinardi, D Brugnoni, E Quiròs-Roldan, A Malagoli, S La Grutta, A Correra, L D Notarangelo. Blood 1997
157
33


Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
31

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
31

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
232
29

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
307
29

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
117
28

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
497
28

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
U Dianzani, M Bragardo, D DiFranco, C Alliaudi, P Scagni, D Buonfiglio, V Redoglia, S Bonissoni, A Correra, I Dianzani,[...]. Blood 1997
129
26

The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
A J Infante, H A Britton, T DeNapoli, L A Middelton, M J Lenardo, C E Jackson, J Wang, T Fleisher, S E Straus, J M Puck. J Pediatr 1998
88
29

Pathological findings in human autoimmune lymphoproliferative syndrome.
M S Lim, S E Straus, J K Dale, T A Fleisher, M Stetler-Stevenson, W Strober, M C Sneller, J M Puck, M J Lenardo, K S Elenitoba-Johnson,[...]. Am J Pathol 1998
146
25

Chronic lymphadenopathy simulating malignant lymphoma.
V C Canale, C H Smith. J Pediatr 1967
145
23

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
195
22

Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder.
Y Kasahara, T Wada, Y Niida, A Yachie, H Seki, Y Ishida, T Sakai, F Koizumi, S Koizumi, T Miyawaki,[...]. Int Immunol 1998
72
29

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.
A K Vaishnaw, J R Orlinick, J L Chu, P H Krammer, M V Chao, K B Elkon. J Clin Invest 1999
124
21

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
230
20

Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
M van der Burg, R de Groot, W M Comans-Bitter, J C den Hollander, H Hooijkaas, H J Neijens, R M Berger, A P Oranje, A W Langerak, J J van Dongen. Pediatr Res 2000
41
48

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
261
19

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
T Takahashi, M Tanaka, C I Brannan, N A Jenkins, N G Copeland, T Suda, S Nagata. Cell 1994
17

Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
J J Bleesing, M R Brown, S E Straus, J K Dale, R M Siegel, M Johnson, M J Lenardo, J M Puck, T A Fleisher. Blood 2001
93
18

Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Aude Magerus-Chatinet, Bénédicte Neven, Marie-Claude Stolzenberg, Cécile Daussy, Peter D Arkwright, Nina Lanzarotti, Catherine Schaffner, Sophie Cluet-Dennetiere, Filomeen Haerynck, Gérard Michel,[...]. J Clin Invest 2011
78
21

The Fas death factor.
S Nagata, P Golstein. Science 1995
16


Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
D A Martin, L Zheng, R M Siegel, B Huang, G H Fisher, J Wang, C E Jackson, J M Puck, J Dale, S E Straus,[...]. Proc Natl Acad Sci U S A 1999
145
14

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.
U Lopatin, X Yao, R K Williams, J J Bleesing, J K Dale, D Wong, J Teruya-Feldstein, S Fritz, M R Morrow, I Fuss,[...]. Blood 2001
74
18

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
R M Siegel, J K Frederiksen, D A Zacharias, F K Chan, M Johnson, D Lynch, R Y Tsien, M J Lenardo. Science 2000
499
14

Fas and Fas ligand: lpr and gld mutations.
S Nagata, T Suda. Immunol Today 1995
809
13

Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
Kennichi C Dowdell, Julie E Niemela, Susan Price, Joie Davis, Ronald L Hornung, João Bosco Oliveira, Jennifer M Puck, Elaine S Jaffe, Stefania Pittaluga, Jeffrey I Cohen,[...]. Blood 2010
77
16

Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.
M Benkerrou, F Le Deist, J P de Villartay, S Caillat-Zucman, F Rieux-Laucat, N Jabado, M Cavazzana-Calvo, A Fischer. Eur J Immunol 1997
32
37

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Manuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, Sara Calleja, Jose Gomez-Rial, Ernesto Roldan, Pablo Morales, Antonio Serrano, Alberto Anel, Estela Paz-Artal,[...]. Blood 2006
79
15

FAS haploinsufficiency is a common disease mechanism in the human autoimmune lymphoproliferative syndrome.
Hye Sun Kuehn, Iusta Caminha, Julie E Niemela, V Koneti Rao, Joie Davis, Thomas A Fleisher, João B Oliveira. J Immunol 2011
38
31

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.
M Lenardo, K M Chan, F Hornung, H McFarland, R Siegel, J Wang, L Zheng. Annu Rev Immunol 1999
783
11

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
J J Bleesing, S E Straus, T A Fleisher. Pediatr Clin North Am 2000
61
18

Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
U Ramenghi, S Bonissoni, G Migliaretti, S DeFranco, F Bottarel, C Gambaruto, D DiFranco, R Priori, F Conti, I Dianzani,[...]. Blood 2000
81
13

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche,[...]. Blood 2009
96
11

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
Lilia L Bi, George Pan, T Prescott Atkinson, Lixin Zheng, Janet K Dale, Christopher Makris, Vishnu Reddy, Jay M McDonald, Richard M Siegel, Jennifer M Puck,[...]. BMC Med Genet 2007
50
20

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
148
10

Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome.
Iusta Caminha, Thomas A Fleisher, Ronald L Hornung, Janet K Dale, Julie E Niemela, Susan Price, Joie Davis, Katie Perkins, Kennichi C Dowdell, Margaret R Brown,[...]. J Allergy Clin Immunol 2010
57
17

Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation.
B J Sleight, V S Prasad, C DeLaat, P Steele, E Ballard, R J Arceci, C L Sidman. Bone Marrow Transplant 1998
38
23

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis.
L Pensati, A Costanzo, A Ianni, D Accapezzato, R Iorio, G Natoli, R Nisini, C Almerighi, C Balsano, P Vajro,[...]. Gastroenterology 1997
53
16

Cell-death signaling and human disease.
Frédéric Rieux-Laucat, Alain Fischer, Françoise Le Deist. Curr Opin Immunol 2003
90
10

A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
Bénédicte Neven, Aude Magerus-Chatinet, Benoit Florkin, Delphine Gobert, Olivier Lambotte, Lien De Somer, Nina Lanzarotti, Marie-Claude Stolzenberg, Brigitte Bader-Meunier, Nathalie Aladjidi,[...]. Blood 2011
89
10


Structure of the human APO-1 gene.
I Behrmann, H Walczak, P H Krammer. Eur J Immunol 1994
149
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.